Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing study of topiroxostat in hyperuricemia with or without gout
jRCT1080223727Completed
- Sponsor
- Fuji Yakuhin
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of topiroxostat in hyperuricemia and gout, sponsored by Fuji Yakuhin. Started Nov 2017; status: completed.
02
Drugs
topiroxostat
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on jRCT1080223727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223727.